Mardi Dier, SVP and CFO at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 3,922 shares at $325.89 ($1.3M) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Scheduled sale ($1.3M) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $323.54 | 774 | $250K | 19.6% |
| 2 | $323.54 | 774 | $250K | 19.6% |
| 3 | $325.89 | 1,187 | $387K | 30.4% |
| 4 | $325.89 | 1,187 | $387K | 30.4% |
| Total | $324.96 avg | 3,922 | $1.3M | 100% |
| Filing → |
| MDGL | SELL | 2025-12-03 | $3.6M | — | Filing → |
| MDGL | SELL | 2025-03-12 | $167K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $116K | — | Filing → |